Transcriptional Profiling of Non-Small Cell Lung Cancer Cells with Activating EGFR Somatic Mutations
2007

Transcriptional Profiling of Non-Small Cell Lung Cancer Cells with Activating EGFR Somatic Mutations

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Choi Kuicheon, Creighton Chad J., Stivers David, Fujimoto Nobukazu, Kurie Jonathan M.

Primary Institution: M. D. Anderson Cancer Center, The University of Texas

Hypothesis

What are the transcriptional mediators of EGFR in non-small cell lung cancer cells with activating mutations?

Conclusion

The study identified genes associated with EGFR-mutant non-small cell lung cancer that could be targeted for clinical intervention.

Supporting Evidence

  • EGFR-mutant NSCLC cells have a unique transcriptional profile.
  • Two genes, EphA2 and PTGS2, were identified as promoting the growth of EGFR-mutant NSCLC cells.
  • Statistical analysis showed significant differences in gene expression between EGFR-mutant and wild-type cell lines.

Takeaway

Scientists studied lung cancer cells to find out how certain mutations in a gene called EGFR affect their behavior, which could help in treating the disease.

Methodology

The researchers used genetic and pharmacologic approaches to profile the transcriptomes of NSCLC cell lines with and without EGFR mutations.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001226

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication